Mode
Text Size
Log in / Sign up
N/A N=13 Randomized

Physical Activity in Children With Type 1 Diabetes Study

Type 1 Diabetes Mellitus · Physical Activity

Enrolled (actual)
13
Serious AEs
0.0%
Results posted
Aug 2015
Primary outcome: Primary: Feasibility: Response Rate — 4; 4 number of participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Steps To Active Kids (STAK) programme (Behavioral)
Age
Pediatric · 9+ yrs
Sex
All
Sponsor
University of Nottingham
Primary completion
Apr 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility: Response Rate
5; 5
PRIMARY
Feasibility: Response Rate
5; 5
PRIMARY
Feasibility: Rate of Adherence to the Intervention
75
PRIMARY
Feasibility: Number of Participants With Adverse Events
SECONDARY
Change in Children's Self-efficacy Using CSAPPA Scale (Children's Self-Perceptions of Adequacy in and Predilection for Physical Activity)
SECONDARY
Change in Children's Level of Physical Activity (Measured Subjectively Via Self-report Questionnaire)
SECONDARY
Change in Clinical Outcome Measures (Hba1c, Height, Weight)
SECONDARY
Change in Parental Hypoglycaemia Fear Using the Hypoglycaemia Fear Survey (HFS-Parent)

Summary

This study aims to test the feasibility of a physical activity intervention called the Steps To Active Kids (STAK) programme in children aged 9 - 11 years with Type 1 Diabetes Mellitus (T1DM).

Eligibility Criteria

Inclusion Criteria

  • Be aged between 9 and 11 years
  • Have a clinical diagnosis of Type 1 Diabetes Mellitus for at least 3 months
  • Be willing and able to comply with the study protocol
  • Be physically able to participate in physical activity
  • Have a parent/carer who provides informed consent

Exclusion Criteria

  • Be under the age of 9 years and over the age of 11 years
  • Have been diagnosed with Type 1 Diabetes Mellitus for less than 3 months
  • Have an injury or physical health condition that precludes their participation in physical activity
  • Have a psychiatric disorder that interferes with provision of assent, completion of measurements, intervention, or follow-up
  • Insufficient proficiency in English to comply with treatment or provide data
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02144337). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search